Engineers Gate Manager LP Agenus Inc Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.53 - $0.93 $613 - $1,076	-1,158 Reduced 1.5%	76,053 $44,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $109 - $198	174 Added 0.23%	77,211 $64,000
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $17,721 - $29,747	15,823 Added 25.85%	77,037 $87,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $80,190 - $124,876	61,214 New	61,214 $97,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $122,699 - $196,570	62,602 New	62,602 $128,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $61,399 - $124,687	-47,230 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $110,990 - $163,888	47,230 New	47,230 $116,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.